These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 4154180)
1. A pilot investigation of clinical effects of PM-33, a new anti-anxiety agent. Abuzzahab FS; Kulkarni AS Curr Ther Res Clin Exp; 1974 Nov; 16(11):1181-6. PubMed ID: 4154180 [No Abstract] [Full Text] [Related]
2. Pilot open-label study on U-31,889 in anxious in-patients. Fabre LF; Harris RT Curr Ther Res Clin Exp; 1974 Sep; 16(9):1010-3. PubMed ID: 4154181 [No Abstract] [Full Text] [Related]
3. Clinical assessment of lorazepam in anxiety: a double-blind study. Olgiati SG Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741 [No Abstract] [Full Text] [Related]
5. Validation of a physician rating scale for investigation of antianxiety effects of drugs [proceedings]. Free SM; Overall JE Psychopharmacol Bull; 1977 Apr; 13(2):8-11. PubMed ID: 16312 [No Abstract] [Full Text] [Related]
6. A preliminary double-blind study with SB 5833 (camazepam), a new benzodiazepine derivative. Cesa-Bianchi M; Ghirardi P; Ravaccia F Arzneimittelforschung; 1974 Dec; 24(12):2032-5. PubMed ID: 4156178 [No Abstract] [Full Text] [Related]
7. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
8. [Double-blind trial treatment of anxiety with b 5833]. Cloquette R Acta Psychiatr Belg; 1974 May; 74(3):317-26. PubMed ID: 4156149 [No Abstract] [Full Text] [Related]
9. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study. Ananth V; Beszterczy A; Geagea C Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825 [No Abstract] [Full Text] [Related]
12. A double-blind investigation of dimethacrine versus imipramine in hospitalized depressive states. Abuzzahab FS Int J Clin Pharmacol; 1973 Nov; 8(3):244-53. PubMed ID: 4149236 [No Abstract] [Full Text] [Related]
13. Buspirone--a new antianxiety agent not chemically related to any presently marketed drugs [proceedings]. Goldberg HL Psychopharmacol Bull; 1979 Apr; 15(2):90-2. PubMed ID: 34846 [No Abstract] [Full Text] [Related]
14. A controlled comparison of chlorazepate with oxazepam in neurotic anxiety. Boucek J; Vinar O; Novák A Act Nerv Super (Praha); 1974 Aug; 16(3):239-40. PubMed ID: 4153915 [No Abstract] [Full Text] [Related]
16. Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties. Ekblom B; Haggstrom JE Curr Ther Res Clin Exp; 1974 Sep; 16(9):945-57. PubMed ID: 4154183 [No Abstract] [Full Text] [Related]
17. Placebo response in generalized anxiety: its effect on the outcome of clinical trials. Schweizer E; Rickels K J Clin Psychiatry; 1997; 58 Suppl 11():30-8. PubMed ID: 9363046 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of anxiety with bromazepam in clinical practice (author's transl)]. Bornstein S; Benoudich H; Kaufman E; Konqui M; Pigeon P Nouv Presse Med; 1982 May; 11(22):1731-4. PubMed ID: 6124945 [TBL] [Abstract][Full Text] [Related]
19. Alprazolam in the treatment of neurotic anxiety. Kerry RJ; McDermott CM Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462 [TBL] [Abstract][Full Text] [Related]